First successful protocol for desensitization to eptinezumab
Headache: The Journal of Head and Face Pain · 2026
DOI: 10.1111/head.70000 ↗At a glance
Fallbericht in Headache: The Journal of Head and Face Pain, 2026. Written by Benoit Gerard and 8 co-authors. Institution: Département de pneumologie et d'oncologie thoracique, Centre Hospitalier Universitaire de Nice, IHU RespirERA, Université Côte d'Azur, Nice, France. Major MEDLINE topics: Antibodies, Monoclonal, Humanized, Desensitization, Immunologic, Migraine Disorders, Drug Hypersensitivity. 9 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Eptinezumab is an anti‐calcitonin gene‐related peptide monoclonal antibody used for migraine prevention. During clinical trials, hypersensitivity to eptinezumab was described without a clear underlying mechanism. To determine if the reaction was immunoglobulin E–mediated, the team of Nice University Hospital (Nice, France) performed the eptinzeumab skin tests. A 10‐step desensitization protocol has been proposed to manage these reactions.
Findings
Two patients presenting with immediate hypersensitivity reactions underwent the eptinezumab skin test. Neither skin test was positive, suggesting a non‐immunoglobulin E–mediated mechanism. The patients then completed the desensitization protocol successfully.
Conclusion
This hospital‐based 10‐step desensitization protocol appears safe and effective.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Département de pneumologie et d'oncologie thoracique, Centre Hospitalier Universitaire de Nice, IHU RespirERA, Université Côte d'Azur, Nice, France.
- Pain Department, Centre Hospitalier Universitaire de Nice, FHU Inovpain, URC2A, Université Côte d'Azur, Nice, France.
- INSERM U1107 Migraine and Trigeminal Pain, Auvergne University, Clermont-Ferrand, France.
- Centre régional de pharmacovigilance, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
ORCID profiles: Margot Delin
Cite
APA
Gerard, B., Praudel, H., Lanteri-Minet, M., Van Obberghen, E., Rocher-Moreau, F., Rousset, J., Jacquier, U., Leroy, S., & Delin, M. (2026). First successful protocol for desensitization to eptinezumab. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.70000
Vancouver
Gerard B, Praudel H, Lanteri-Minet M, Van Obberghen E, Rocher-Moreau F, Rousset J, et al. First successful protocol for desensitization to eptinezumab. Headache: The Journal of Head and Face Pain. 2026. doi:10.1111/head.70000
BibTeX
@article{Gerard2026,
author = {Gerard, Benoit and Praudel, Hubert and Lanteri-Minet, Michel and Van Obberghen, Elise and Rocher-Moreau, Fanny and Rousset, Johanna and Jacquier, Ulysse and Leroy, Sylvie and Delin, Margot},
title = {First successful protocol for desensitization to eptinezumab},
journal = {Headache: The Journal of Head and Face Pain},
year = {2026},
doi = {10.1111/head.70000}
}
EUVIMED